Table 1. Characteristics of the study .
Author | Year | Country | Study Type | Type Blinding | Sample Size | Group A | Group B | Initial dose of Propofol | Initial dose of Ketofol | |
Group A | Group B | |||||||||
Ferguson et al (2016) | 2016 | Australia | Randomized-double-blind clinical trial | 2 | 292 | 281 | Propofol | Ketamine + propofol | 1.3 mg/kg | 1.3 mg/kg ketamine and propofol combined |
Miner et al (2015) | 2015 | USA | Randomized-double-blinded trial | 2 | 90 | 85 | Propofol | Ketamine + propofol | 1 mg/kg | 1:1—0.5 mg/kg ketamine and propofol combined; 4:1—0.8 mg/kg ketamine, 0.2 mg/kg propofol |
Andolfatto et al (2012) | 2012 | Canada | Randomized- double-blind trial | 2 | 142 | 142 | Propofol | Ketamine + propofol | 0.75 mg/kg | 0.375 mg/kg ketamine and propofol combined |
David et al (2010) | 2010 | Columbia | Randomized- double-blind- placebo-controlled trial | 2 | 97 | 96 | Propofol | Ketamine + propofol | 1 mg/kg | 0.5 mg/kg ketamine and propofol combined |
Phillips et al (2010) | 2010 | USA | Prospective- randomized single blind | 1 | 14 | 11 | Propofol | Ketamine + propofol | 0.5–1.5 mg/kg | 0.75 mg/kg ketamine and propofol combined |